Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 32 results for "merck co"

Germany's Merck plans divestment of biosimilars business

Merck has a strategic alliance with India's Dr Reddy's Labs to co-develop multiple cancer drugs BS B2B Bureau | Darmstadt, Germany March 14, 2017 Last Updated at 12:37 IST Merck KGaA, the German firm that specialises in chemical, pharmaceutical and life ... Business Standard, 1 month ago

147 images for merck co

WKRB News, 2 months ago
American Banking News, 2 months ago
SleekMoney, 3 months ago
themalaymailonline.com, 2 months ago
Yahoo! News, 3 months ago
reutersmedia.net, 3 months ago
SRN News, 2 months ago
4 Traders, 3 months ago
yimg.com, 2 months ago
Nasdaq, 2 months ago
Money Control

Glenmark partners Evestra to market contraceptive product in US

They have signed pact for a generic version of Merck & Co's NuvaRing, a contraceptive vaginal ring Rakesh Rao | Mumbai March 2, 2017 Last Updated at 10:45 IST Glenmark Pharmaceuticals and the US-based Evestra Inc have completed a strategic development, ...
 Business Standard1 month ago Glenmark, Evestra enter pact for generic contraceptive product  Business Standard1 month ago Glenmark Pharma and Evestra announce partnership agreement for generic NuvaRing  Money Control1 month ago
Reuters

FDA rejects Merck's application to add heart data on diabetes drug labels

Merck & Co said the U.S. Food and Drug Administration declined an application to include information on the labels of its diabetes drugs - Januvia and Janumet - that the treatments do not raise the risk of major heart problems. Merck is reviewing the agency's ...
 Reuters2 weeks ago Merck's Keytruda wins FDA nod for treating blood cancer  Reuters1 month ago Merck 2017 forecast reassuring; full-speed ahead with Keytruda  Reuters2 months ago

UK rejects Merck's Keytruda as initial treatment for lung cancer

LONDON (Reuters) - Britain's healthcare watchdog NICE, which assesses the cost-effectiveness of medical treatments, has stopped short of recommending the use by the National Health Service (NHS) of Merck & Co Inc's immunotherapy drug Keytruda in newly ...
 Reuters1 month ago

The cost of cancer: new drugs show success at a steep price

The drugs' success for patients is the result of big bets in cancer therapy made by Bristol-Myers Squibb Co, Merck & Co Inc and Roche Holding AG, among others in big pharma.
 DNA3 weeks ago
Sify

Trump meets with drugmakers, seeks lower prices, U.S. production

Trump met with the CEOs of Novartis AG, Merck & Co Inc, Johnson & Johnson, Celgene Corp, Eli Lilly & Co, Amgen Inc as well as the head of the industry's lobbying group, the Pharmaceutical Research and Manufacturers of America.
 DNA2 months ago Trump pushes drugmakers for lower prices, more U.S. production  Sify2 months ago

Merck reveals 7 years of its U.S. drug price increase history

n">Merck & Co ( MRK.N ) on Friday posted seven years of information showing a high single-digit percentage annual average price hike across its portfolio of medicines in a move that provides new details on its pricing practices for the U.S. market.
 Reuters2 months ago

Merck must face renewed Fosamax warning claims: U.S. appeals court

A federal appeals court on Wednesday revived claims by several hundred plaintiffs who accused Merck & Co of failing to adequately warn about the risks of thigh bone fractures associated with its osteoporosis drug Fosamax. In a 3-0 decision, the 3rd U.S.
 Reuters1 month ago

Merck drug prevents serious infection after marrow transplant: study

An experimental Merck & Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with placebo in a late state study, the company said. Merck said it will ...
 Reuters1 month ago Merck stopping late stage study as another Alzheimer's drug fails  Reuters2 months ago
Reuters

Roche cancer drug taking bite out of Bristol's Opdivo

Roche's cancer drug Tecentriq hit the market months behind immuno-oncology (I/O) medicines from Merck and Bristol-Myers Squibb Co but the Swiss drugmaker's treatment is making up lost ground. On Thursday, Bristol-Myers managers said Tecentriq is grabbing ...
 Reuters2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less